GROWNSY Reaches 3 Million Households as Baby Care Brand Caps Breakthrough Year
Company credits parent feedback initiative and ISO 13485 medical-grade manufacturing standards for rapid growth NEW YORK, Dec. 17, 2025 /PRNewswire/ -- Grownsy, a baby care products company specializing in creating innovative baby care products designed to fit seamlessly into modern family life., announced today that its products are now used in over 3 million households globally, marking a significant...
MEDI&GENE Announces Catalyze Agreement with Lilly to Advance Next-Generation Obesity Therapeutics
SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ -- MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreement with Eli Lilly and Company (Lilly) to advance a next-generation therapeutic for obesity. MEDI&GENE Announces Catalyze Agreement with Lilly to Advance Next-Generation Obesity Therapeutics MEDI&GENE's discovery platform is designed to unlock novel therapeutic pathways...
Rona Therapeutics Unveils the Global First Bi-valent PCSK9-LPA siRNA into Clinical Development for Cardiovascular Risk Reduction
SHANGHAI and SANTA BARBARA, Calif., Dec. 17, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in next-generation RNAi medicines, today announced the submission of RN5681 to the Australian Human Research Ethics Committee (HREC), advancing the company's first bi-valent siRNA into clinical development. The Phase 1 trial is expected to begin dosing in...
Bioptimus Unveils M-Optimus, a World Model for Biology
Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical innovation The Unveiling of M-Optimus: Bioptimus has trained its inaugural World Model for biology - a foundation model that learns interactions across multiple languages of biology - marking a revolutionary first...
Health on hold: Nearly 60% of Hongkongers surveyed delay medical care
Delays driven by family obligations and fear of becoming a burden highlight a growing health concern HONG KONG, Dec. 17, 2025 /PRNewswire/ -- The findings of the study Patient Voices Hong Kong: How clarity, cost and choice shape care, a new Economist Impact report commissioned by Prudential plc, highlight the challenges faced by Hong...
CUHK and MicroSigX partner to launch a breakthrough test aiding early autism diagnosis offering 200 free test quotas
HONG KONG, Dec. 17, 2025 /PRNewswire/ -- The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) announced the official launch of the world's first "AI-Powered Multikingdom Microbial Biomarkers Technology" (MSX Metagenie®) today, in collaboration with MicroSigX Biotech Diagnostic Limited, a CUHK spin-off. This innovative technology detects risk of autism spectrum disorder (ASD) in children, enabling early...
Everest Medicines Announces that Licensing Partner LIB Therapeutics has Received U.S. FDA Approval of LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol
SHANGHAI, Dec. 17, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has approved LEROCHOL™ (lerodalcibep-liga) injection from LIB Therapeutics, for subcutaneous use as an adjunct to diet and exercise to reduce...
Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG
Highlighting advances in vascular aging research and microalgae-based Omega-3 innovation SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- The 5th World Biological Science and Technology Conference 2025 Singapore (BioST 2025 SG) opened in Singapore, bringing together leading researchers and industry experts from the global biotechnology sector. The pioneer longevity brand infinityseek was invited to participate in the event, where it formally unveiled...
111, Inc. Announces Third Quarter 2025 Unaudited Financial Results
Transition from An Asset-Heavy Business Model to An Asset-Light Business Model Achieved Quarterly Non-GAAP Net Profitability Maintained Non-GAAP Operational Profitability for Three Consecutive Quarters Achieved Quarterly Positive Operating Cash Flow SHANGHAI, Dec. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of...
LightingWay Counselling Offers Affordable Therapy Amid Rising Job Market Uncertainty in Singapore
SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- Recent employment data reveals heightened job market pressures affecting mental health needs. In light of these circumstances, LightingWay Counselling & Therapy continues to provide affordable therapy services to help Singaporeans cope better with a complex, evolving job market. Singaporeans Continue to Face Job Market Challenges Going into 2026 As artificial intelligence...
